KOSDAQ - Delayed Quote KRW
APT Neuroscience, Inc. (270520.KQ)
1,184.00
-31.00
(-2.55%)
At close: 3:30:30 PM GMT+9
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
18,377,623.94
18,377,623.94
20,415,365.64
17,563,145.10
25,134,889.53
Cost of Revenue
17,662,002.20
17,662,002.20
19,863,893.75
19,026,210.07
22,561,299.25
Gross Profit
715,621.74
715,621.74
551,471.89
-1,463,064.97
2,573,590.28
Operating Expense
13,467,764
13,467,764
7,097,777
1,669,515
3,693,832
Operating Income
-12,752,142.26
-12,752,142.26
-6,546,305.11
-3,132,579.97
-1,120,241.72
Net Non Operating Interest Income Expense
-25,833.73
-25,833.73
-1,280,870.07
261,796.15
58,558.30
Pretax Income
-19,018,369.11
-19,018,369.11
-4,457,294.09
-3,984,849.06
-1,113,718.09
Tax Provision
148,436.68
148,436.68
546,138.87
-737,047.14
-183,392.24
Net Income Common Stockholders
-19,166,805.80
-19,166,805.80
-5,003,432.97
-3,247,801.92
-930,325.84
Basic EPS
-130.00
--
-41.00
-11.67
-10.00
Diluted EPS
-130.00
--
-59.00
-11.67
-10.00
Basic Average Shares
147,436.97
--
122,034.95
93,686.59
93,032.58
Diluted Average Shares
147,436.97
--
84,803.95
93,686.59
93,032.58
Total Operating Income as Reported
-12,752,142.08
-12,752,142.08
-6,546,305.54
-3,132,579.50
-1,120,241.59
Rent Expense Supplemental
395,313
395,313
33,363
7,581
4,440
Total Expenses
31,129,766.20
31,129,766.20
26,961,670.75
20,695,725.07
26,255,131.25
Net Income from Continuing & Discontinued Operation
-19,166,805.80
-19,166,805.80
-5,003,432.97
-3,247,801.92
-930,325.84
Normalized Income
-20,185,192.88
-20,185,192.88
-10,913,764.49
-2,436,048.08
-1,013,907.62
Interest Income
2,752,611
2,752,611
2,156,557
315,510
64,325
Interest Expense
2,778,445
2,778,445
3,404,705
53,713
5,767
Net Interest Income
-25,833.73
-25,833.73
-1,280,870.07
261,796.15
58,558.30
EBIT
-16,239,924.11
-16,239,924.11
-1,052,589.09
-3,931,136.06
-1,107,951.09
EBITDA
-15,075,933.11
-15,075,933.11
-542,932.09
-3,815,546.06
-990,694.09
Reconciled Cost of Revenue
17,662,002.20
17,662,002.20
19,863,893.75
19,026,210.07
22,561,299.25
Reconciled Depreciation
1,163,991
1,163,991
509,657
115,590
117,257
Net Income from Continuing Operation Net Minority Interest
-19,166,805.80
-19,166,805.80
-5,003,432.97
-3,247,801.92
-930,325.84
Total Unusual Items Excluding Goodwill
1,339,983
1,339,983
7,776,752
-995,971
100,058
Total Unusual Items
1,339,983
1,339,983
7,776,752
-995,971
100,058
Normalized EBITDA
-16,415,916.11
-16,415,916.11
-8,319,684.09
-2,819,575.06
-1,090,752.09
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
321,595.92
321,595.92
1,866,420.48
-184,217.16
16,476.22
12/31/2021 - 8/22/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade